Models of interaction between metabolic genes and environmental exposure in cancer susceptibility

Environmental Health Perspectives

Volumn 106, Issue 2, 1998, Pages 67-70

  Taioli, Emanuela ^a,b,d   Zocchetti, Carlo ^c   Garte, Seymour ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MILAN   (Italy)

^c Clinica del Lavoro   (Italy)

^d FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Biomarkers; Case control; Epidemiology; Logistic regression; Polymorphisms

Indexed keywords

TOBACCO SMOKE; TUMOR MARKER;

ARTICLE; CANCER SUSCEPTIBILITY; CONCENTRATION RESPONSE; ENVIRONMENTAL EXPOSURE; GENE; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; LUNG CANCER; METABOLISM; PRIORITY JOURNAL; REGRESSION ANALYSIS;

NICOTIANA TABACUM;

EID: 0031939357     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.9810667     Document Type: Article

References (27)

1. Hirayama T. Family history in childhood malignancies with special reference to genetic-environmental interaction. In: Genetic Epidemiology of Cancer (Lynch HT, Hirayama T, eds). Boca Raton FLCRC Press, 1989;111-117.
2. Hegele RA. Gene-environment interactions in atherosclerosis. Mol Cell Biochem 113(2):177-186 (1992).
3. Hwang SJ, Beaty TH, Panny SR, Street NA, Joseph JM, Gordon S, Me Intosh I, Francomano CA. Association study of transforming growth factor alpha (TGF alpha) Taql polymorphism and oral clefts: indication of gene-environment interaction in a population-based sample of infants with birth defects. Am J Epidemiol 141(7):629-636 (1995).
4. Brennan P, Silman AJ. An investigation of geneenvironment interaction in the etiology of rheumatoid arthritis. Am J Epidemiol 140(5):453-460 (1994).
5. Havden MR, Liu MS, Ma Y. Gene environment interaction and plasma triglyceride levels: the crucial role of lipoprotein lipase. Clin Genet 46(1 Spec No):15-18 (1994).
6. Tiret L, Abel L, Rakotovao R. Effect of ignoring genotype-environment interaction on segregation analysis of quantitative traits, Genet Epidemiol 10(6):581-586 (1993).
7. Hirvonen A. Genetic factors in individual responses to environmental exposures. J Occup Environ Med 37(1):37-43 (1995).
8. Herris CC. Interindividual variation among humans in carcinogen metabolism, DNA adduct formation and DNA repair, Carcinogenesis 10(9):1563-1566 (1989).
9. Hulka BS, Epidemiological studies using biological markers: issues for epidemiologists. Cancer Epidemiol Biomarkers Prev 1:13-19 (1991).
10. Khoury MJ, James LM. Population and familial relative risks of disease associated with environmental factors in the presence of gene-environment interaction. Am J Epidemiol 137(11):1241-1250 (1993).
11. Khoury MJ, Wagener DK, Epidemiological evaluation of the use of genetics to improve the predictive value of disease risk factors. Am J Hum Genet 56(4):835-844 (1995).
12. Ottman R. An epidemiologic approach to gene-environment interaction. Genet Epidemiol 7:177-185 (1990).
13. Nakachi K, Imai K, Hayashi S, Kawajiri K. Polymorphisms of the CYP1A1 and glutathione Stransferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res 53:2994-2999 (1993).
14. Taioli E, Crofts F, Demopoulos R, Trachman J, Toniolo P, Garte SJ. An African-American specific CYP1A1 polymorphism is associated with adenocarcinoma of the lung. Cancer Res 55:472-473 (1995).
15. Vineis P, Bartsch H, Caporaso N, Harrington A, Kadlubar FF, Landi MI, Malaveille C, Shields PG, Skipper P, Talaska G. Genetically based N-acetyltransferase metabolic polymorphism and low level environmentel exposure to carcinogens. Nature 369:154-156 (1994).
16. Taioli E, Garte SJ. Lung cancer risk in AfricanAmericans in relation to a race-specific CYP1A1 polymorphism [letter]. Cancer Res 56:4275-4277 (1996).
17. Vineis P. Molecular epidemiology: low dose carcinogens and genetic susceptibility. Int J Cancer 71:1-3 (1997).
18. Garte SJ, Zocchetti C, Taioli E. Gene-environment interactions in the application of biomarkers of cancer susceptibility in epidemiology. In: Methodological Issues in the Use of Biomarkers in Cancer Epidemiology (Toniolo P, Boffetta P, Shuker D, Hulka B, Pearce N, Rothman N, eds). Lyon:International Agency for Research on Cancer, 1997;251-264.
19. Hirvonen A, Husgafvel-Pursianen K, Anttila S, Vainio H, The GSTM1 null genotype as a potential risk modifier for squamous cell carcinoma of the lung. Carcinogenesis 14:U79-H81 (1993).
20. Kihara M, Kihara M, Noda K. Lung cancer risk of GSTM1 null genotype is dependent on the extent of tobacco smoke exposure. Carcinogenesis 15:415-418 (1994).
21. Smith CM, Kelsey KT, Wiencke JK, Leyden K, Levin S, Christiani DC. Inherited glutathione-5-transferase defiency is a risk factor for pulmonary asbestosis. Cancer Epidemiol Biomarkers Prev 3:471-477 (1994).
22. Crofts F, Taioli E, Trachman J, Cosma GN, Currie D, Toniolo P, Garte SJ, Functional significance of different human CYP1A1 genotypes, Carcinogenesis 15:2961-2963 (1994).
23. Landi MT, Bertazzi PA, Shields PG, Clark G, Lucier GW, Garte SJ, Cosma G, Caporaso NE. Restriction fragment length polymorphism, mRNA expression and enzymatic product of CYP1A1 gene in humans. Pharmacogenetics 4:242-246 (1994).
24. Cosma G, Crofts F, Currie D, Wirgin I, Toniolo P, Garte SG. Racial differences in restriction fragment length polymorphisms and messenger RNA inducibility of the human CYP1A1 gene. Cancer Epidemiol Biomarkers Prev 2:53-57 (1993).
25. Taioli E, Crofts F, Trachman J, Bayo S, Bradlow L, Toniolo P, Garte SJ. Racial differences in CYP1A1 genotype and function. Toxicol Lett 77:357-362 (1995).
26. Nakacni K, Imai K, Hayashi S, Watanabe J, Kawajiri K. Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. Cancer Res 51:5177-5181 (1991).
27. Brown CC, Chu KG. Additive and multiplicative models and multistage Carcinogenesis theory. Risk Anal 9:99-105 (1989).